微信扫码关注“小狗文献”

即刻体验更多权益

文献多,下载快,翻译准

首页 > 医学词汇大全 > percutaneous radiofrequency ablation
percutaneous radiofrequency ablation

肿瘤

关键词肿瘤 治疗方法 肿瘤消融

词汇介绍

拓展阅读

解析

Percutaneous   英 /,pɜːkjʊ'teɪnɪəs/   美 /,pɝkju'tenɪəs/

       adj. 经皮的;经由皮肤的

       Objective: TO investigate the nursing and observation of bleeding after percutaneous coronary interventions (PCI), so as to alleviate the painful and treat the complication of bleeding in time. 目的:探讨经皮冠状动脉介入术后出血并发症的观察与护理,以减轻病人的痛苦,减少和及时处理术后出血并发症。

 

Radiofrequency   /,reidiəu-'fri:kwənsi/

       n. 高频,射频;高周波

       Mobile phones are often prohibited in hospitals and on airplanes, as the radiofrequency signals may interfere with certain electro-medical devices and navigation systems. 由于射频信号可能会干扰某些电子医疗装置和导航系统,在医院里和飞机上通常禁止使用移动电话。

 

Ablation   英 /ə'bleɪʃ(ə)n/   美 /ə'bleʃən/

       n. [水文] 消融;切除

同根词   ablative adj. 离格的;消融的;ablative n. 烧蚀材料;离格;

       But if these go to plan, fewer procedures like cardiac ablation will need to be repeated, lowering the number of readmissions, and with it cost of treatment. 不过如果一切都按计划进行,那么心脏消融术重复的次数就可以减少,从而降低再次入院的次数和治疗费用。

概述

经皮肿瘤消融(percutaneous tumor ablation)是指在明确肿瘤的部位和性质后,在CT或B超的导向之下,准确穿刺命中靶点——肿瘤,利用物理或化学的方法直接消灭或融解癌组织。消融又分为物理消融和化学消融。物理消融是进行肿瘤穿刺后放入微波天线或者射频电极,利用电磁波在组织内进行加热的原理,使癌组织凝固坏死,经皮射频消融治疗就是其中一种物理消融的方法。射频是一定特定频率的电磁波,医用射频频率为460-500 KHz。医用射频电磁波可激活组织内部的极性分子产生电磁振荡产

Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses复制标题

肾部分切除术和经皮消融治疗cT1肾肿块后的肿瘤学结果

发表时间:2019-08-01

影响因子:17.3

作者: Jack R. Andrews

期刊:Eur. Urol.

Following Institutional Review Board approval, we identified patients treated with PN, percutaneous radiofrequency ablation (RFA), or percutaneous cryoablation at our institution for sporadic, localized (N0M0), cT1 solid renal mass between 2000 and 2011, as published in 2015. The cT1 renal masses were defined as renal masses ≤7 cm identified on imaging as per the 2016 AJCC cancer staging manual. All renal masses with radiographic evidence of extension beyond the kidney or extension into the renal or segmental veins were excluded from analysis, as were patients with a history of prior RCC or genetic syndromes. A total of 1422 patients were treated with PN (N = 1055), RFA (N = 180), or cryoablation (N = 187) for cT1aN0M0 renal masses, and 376 patients were treated with PN (N = 324) or cryoablation (N = 52) for cT1bN0M0 renal masses. Since the previous analysis, four patients (three PN and one cryoablation) were excluded because of research authorization refusals and one patient was excluded due to previously unrecorded M1 disease at PN. Patient surveillance was generally recommended at 3, 6, 12, 18, and 24 mo, followed by yearly intervals; variance from this protocol was based on pathologic features and clinical health status.

译文

在机构审查委员会批准后,我们确定了2000年至2011年期间在我们的机构接受PN,经皮射频消融术(RFA)或经皮冷冻消融术治疗的散发性局部(N0M0),cT1实体肾脏肿块患者,于2015年发布.cT1肾脏肿块定义为根据2016年AJCC癌症分期手册在成像时鉴定的≤7cm的肾脏肿块。所有具有超出肾脏或延伸至肾脏或节段静脉的放射照相证据的肾脏肿块均被排除在分析之外,具有既往RCC或遗传综合征病史的患者也被排除在外。对于cT1aN0M0肾脏肿块,共有1422名患者接受PN(N = 1055),RFA(N = 180)或冷冻消融(N = 187)治疗,376名患者接受PN(N = 324)或冷冻消融治疗(N = 52)对于cT1bN0M0肾脏肿块。自上次分析以来,由于研究授权拒绝而排除了4名患者(3名PN和1名冷冻消融术),并且由于先前未记录的M1疾病,因此排除了一名患者。通常建议在3,6,12,18和24个月进行患者监测,然后每年进行一次;该方案的差异基于病理特征和临床健康状况。